Cargando…
Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017
Mycoplasma genitalium infections of the urogenital tract are usually treated with azithromycin; however, for the past several years, rates of azithromycin treatment failure have increased. To document the occurrence and frequency of macrolide resistance–mediating mutations (MRMMs) in M. genitalium i...
Autores principales: | Martens, Liesbeth, Kuster, Sharon, de Vos, Wilco, Kersten, Maikel, Berkhout, Hanneke, Hagen, Ferry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590771/ https://www.ncbi.nlm.nih.gov/pubmed/31211669 http://dx.doi.org/10.3201/eid2507.181556 |
Ejemplares similares
-
Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017
por: Adelantado, Marta, et al.
Publicado: (2019) -
Macrolide Resistance in Mycoplasma genitalium in Singapore
por: Barkham, Timothy, et al.
Publicado: (2017) -
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
por: Murray, Gerald L., et al.
Publicado: (2017) -
Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection
por: Read, Tim R.H., et al.
Publicado: (2018) -
Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007–2014
por: Muller, Etienne E., et al.
Publicado: (2019)